Rojkjaer Lisa - Insider Non-Derivative Transactions at Viracta Therapeutics, Inc. (VIRX) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Feb 27, 2023, Rojkjaer Lisa's relationship to Viracta Therapeutics, Inc. (VIRX) is Officer (Chief Medical Officer), and currently has 48,087 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other VIRX insiders.

Data Source: SEC.
Rojkjaer Lisa - Insider Non-Derivative Transactions of VIRX Common Stock
Rojkjaer Lisa - Insider Non-Derivative Transactions at VIRX
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 28, 2023 Sell -- (Common Stock) 2156 1.68 48087
Feb 26, 2023 M -- (Common Stock) 4127 0 50243